Ophthotech Reports Second Quarter 2015 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- Wall St indexes climb as US, Iran halt attacks; Comcast surges on spin-off plan
- Tech funds suffer record outflows as investors trim equity positions
- Comcast shares surge 23% on blockbuster plan to spin off NBCUniversal and Sky
- New leader board: Citi refreshes AI compute semiconductor picks
- Martin Marietta confirms $13.5B deal for Lhoist North America
- Needham Starts NeoVolta (NEOV) at Buy
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- Personalis, Inc. (PSNL) and Tempus (TEM) Expand Collaboration
- Strategy stock jumps 7% as firm shifts to active capital management
- Micron ships 245TB data center SSD, claims world's highest capacity
UPDATE: Goldman Sachs Expects Underperformance at Ophthotech (OPHT), Cuts to Sell
August 7, 2015 7:02 AM EDT(Updated - August 7, 2015 9:40 AM EDT)
Goldman Sachs downgraded Ophthotech Corp (NASDAQ: OPHT) from Neutral to Sell with a price target of $45 (unchanged). Analyst Terence Flynn expects share price underperformance due to competitor updates, as well as lack of meaningful catalysts.
"One of the tenants to our thesis has been potential future competition... More
Ophthotech Corp (OPHT) Misses Q2 EPS by 6c
August 5, 2015 7:34 AM EDTOphthotech Corp (NASDAQ: OPHT) reported Q2 EPS of ($1.08), $0.06 worse than the analyst estimate of ($1.02). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.77 million.
For earnings history and earnings-related data on Ophthotech Corp (OPHT) click here.
... More